Study

Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform

WSW, NY, 16th March 2026, FinanceWire … Read More

Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy

WSW, NY, 12th March 2026, FinanceWire … Read More

Motiv8AI Featured in FinTech Futures for Introducing a Human-Centered Approach to AI in Banking

Ramat Gan, Israel, 5th March 2026, FinanceWire … Read More

Logitech G Unveils Global Study Showing Esports Has Entered A Golden Age

LAUSANNE, Switzerland, 2nd March 2026, FinanceWire … Read More